195 related articles for article (PubMed ID: 25211343)
21. The ground state of embryonic stem cell self-renewal.
Ying QL; Wray J; Nichols J; Batlle-Morera L; Doble B; Woodgett J; Cohen P; Smith A
Nature; 2008 May; 453(7194):519-23. PubMed ID: 18497825
[TBL] [Abstract][Full Text] [Related]
22. Improvement of mouse cloning using nuclear transfer-derived embryonic stem cells and/or histone deacetylase inhibitor.
Wakayama S; Wakayama T
Int J Dev Biol; 2010; 54(11-12):1641-8. PubMed ID: 21404185
[TBL] [Abstract][Full Text] [Related]
23. E-cadherin is critical for SC1-induced colony growth of F9 embryonic carcinoma cells.
Du J; Wu Y; Liu Y; Ai Z; Wu H; Shi X; Guo Z; Zhang Y
Cell Physiol Biochem; 2014; 33(2):501-12. PubMed ID: 24556957
[TBL] [Abstract][Full Text] [Related]
24. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
[TBL] [Abstract][Full Text] [Related]
25. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
[TBL] [Abstract][Full Text] [Related]
26. SC1 inhibits the differentiation of F9 embryonic carcinoma cells induced by retinoic acid.
Liu Y; Ren X; Ke J; Zhang Y; Wei Q; Shi Z; Ai Z; Guo Z
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):793-799. PubMed ID: 29945210
[TBL] [Abstract][Full Text] [Related]
27. Completely ES cell-derived mice produced by tetraploid complementation using inner cell mass (ICM) deficient blastocysts.
Wen D; Saiz N; Rosenwaks Z; Hadjantonakis AK; Rafii S
PLoS One; 2014; 9(4):e94730. PubMed ID: 24733255
[TBL] [Abstract][Full Text] [Related]
28. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
29. The use of SC1 (Pluripotin) to support mESC self-renewal in the absence of LIF.
Xiong W; Gao Y; Cheng X; Martin C; Wu D; Yao S; Kim MJ; Liu Y
J Vis Exp; 2009 Nov; (33):. PubMed ID: 19924098
[TBL] [Abstract][Full Text] [Related]
30. Generation of mice derived from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
[TBL] [Abstract][Full Text] [Related]
31. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation.
Cho HJ; Lee CS; Kwon YW; Paek JS; Lee SH; Hur J; Lee EJ; Roh TY; Chu IS; Leem SH; Kim Y; Kang HJ; Park YB; Kim HS
Blood; 2010 Jul; 116(3):386-95. PubMed ID: 20439621
[TBL] [Abstract][Full Text] [Related]
32. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.
Shimada H; Hashimoto Y; Nakada A; Shigeno K; Nakamura T
Biochem Biophys Res Commun; 2012 Jan; 417(2):659-64. PubMed ID: 22172948
[TBL] [Abstract][Full Text] [Related]
33. The combination of inhibitors of FGF/MEK/Erk and GSK3β signaling increases the number of OCT3/4- and NANOG-positive cells in the human inner cell mass, but does not improve stem cell derivation.
Van der Jeught M; O'Leary T; Ghimire S; Lierman S; Duggal G; Versieren K; Deforce D; Chuva de Sousa Lopes S; Heindryckx B; De Sutter P
Stem Cells Dev; 2013 Jan; 22(2):296-306. PubMed ID: 22784186
[TBL] [Abstract][Full Text] [Related]
34. The pluripotency transcription factor OCT4 represses heme oxygenase-1 gene expression.
Petrone MV; Toro A; Vazquez Echegaray C; Francia MG; Solari C; Cosentino MS; Vazquez E; Guberman A
FEBS Lett; 2021 Jul; 595(14):1949-1961. PubMed ID: 34056710
[TBL] [Abstract][Full Text] [Related]
35. Folic Acid Supports Pluripotency and Reprogramming by Regulating LIF/STAT3 and MAPK/ERK Signaling.
Wei T; Jia W; Qian Z; Zhao L; Yu Y; Li L; Wang C; Zhang W; Liu Q; Yang D; Wang G; Wang Z; Wang K; Duan T; Kang J
Stem Cells Dev; 2017 Jan; 26(1):49-59. PubMed ID: 27676194
[TBL] [Abstract][Full Text] [Related]
36. Adult mice generated from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Gifford W; Martin G; Kupriyanov S; Baldwin KK
Nature; 2009 Sep; 461(7260):91-4. PubMed ID: 19672243
[TBL] [Abstract][Full Text] [Related]
37. Functional cardiomyocytes derived from human induced pluripotent stem cells.
Zhang J; Wilson GF; Soerens AG; Koonce CH; Yu J; Palecek SP; Thomson JA; Kamp TJ
Circ Res; 2009 Feb; 104(4):e30-41. PubMed ID: 19213953
[TBL] [Abstract][Full Text] [Related]
38. Pluripotency of a polyploid H1 (ES) cell system without leukaemia inhibitory factor.
Fujikawa-Yamamoto K; Ota T; Miyagoshi M; Yamagishi H
Cell Prolif; 2012 Apr; 45(2):140-7. PubMed ID: 22288737
[TBL] [Abstract][Full Text] [Related]
39. Pleiotropy of glycogen synthase kinase-3 inhibition by CHIR99021 promotes self-renewal of embryonic stem cells from refractory mouse strains.
Ye S; Tan L; Yang R; Fang B; Qu S; Schulze EN; Song H; Ying Q; Li P
PLoS One; 2012; 7(4):e35892. PubMed ID: 22540008
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Oct4-GFP spermatogonial stem cell line and its application in the reprogramming studies.
Youn H; Kim SH; Choi KA; Kim S
J Cell Biochem; 2013 Apr; 114(4):920-8. PubMed ID: 23097321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
